Natalia de Albuquerque Rocha, MD

Article

Diabetes medications and cardiovascular outcome trials: Lessons learned

Author:

Kershaw V. Patel, MD

Natalia de Albuquerque Rocha, MD

Darren K. McGuire, MD, MHSc

Drugs of several classes have demonstrated cardiovascular safety; empagliflozin carries a cardiovascular indication.

• Read More